September 2023

September issue of Pharma Manufacturing

More content from September 2023

Microsoft Teams Image (4)
In part 2 of our series on incretin mimetics, we cover the growth of GLP-1 analogues in obesity
Sept. 14, 2023
Microsoft Teams Image (5)
In the third and final part of our series on incretin mimetics, we address pharma’s efforts to overcome supply and pricing issues
Sept. 14, 2023
Microsoft Teams Image (3)
This three-part series will dig into incretin mimetics, their rise to fame in weight management and what it will take for the drug class to truly transform obesity care
Sept. 14, 2023
Pm2309 Hero 854x480 Automation
How data mesh can help the pharma industry free data from silos
Sept. 14, 2023